• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行期间 STEMI 患者入院情况:欧洲心脏病学会调查。

Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology.

机构信息

Nuffield Department of Population Health, University of Oxford, Oxford, UK.

NIHR Oxford Biomedical Research Centre, UK.

出版信息

Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):210-216. doi: 10.1093/ehjqcco/qcaa046.

DOI:10.1093/ehjqcco/qcaa046
PMID:32467968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7543872/
Abstract

AIMS

The COVID-19 pandemic required a significant redeployment of worldwide healthcare resources. Fear of infection, national lockdowns and altered healthcare priorities have the potential to impact utilisation of healthcare resources for non-communicable diseases. To survey health professionals' views of the impact of the COVID-19 pandemic on the rate and timing of admission of patients with ST-elevation myocardial infarction (STEMI), the European Society of Cardiology (ESC) administered an internet-based questionnaire to cardiologists and cardiovascular nurses across 6 continents.

METHODS AND RESULTS

3101 responses were received from 141 countries across 6 continents. 88.3% responded that their country was in "total lockdown" and 7.1% in partial lockdown. 78.8% responded that the number of patients presenting with STEMI was reduced since the coronavirus outbreak and 65.2% indicated that the reduction in STEMI presentations was >40%. Approximately 60% of all respondents reported that STEMI patients presented later than usual and 58.5% that >40% of STEMI patients admitted to hospital presented beyond the optimal window for primary percutaneous intervention (PCI) or thrombolysis. Independent predictors of the reported higher rate of delayed STEMI presentation were a country in total lockdown, >100 COVID-19 cases admitted locally, and the complete restructuring of the local cardiology service.

CONCLUSION

The survey indicates that the impact of COVID-19 on STEMI presentations is likely to be substantial, with both lower presentations and a higher rate of delayed presentations occurring. This has potentially important ramifications for future healthcare and policy planning in the event of further waves of this pandemic.

摘要

目的

COVID-19 大流行要求全球医疗资源进行重大重新部署。对感染的恐惧、国家封锁和医疗优先事项的改变有可能影响非传染性疾病的医疗资源利用。为了调查卫生专业人员对 COVID-19 大流行对 ST 段抬高型心肌梗死(STEMI)患者入院率和时间的影响的看法,欧洲心脏病学会(ESC)向六大洲的心脏病专家和心血管护士进行了一项基于互联网的问卷调查。

方法和结果

共收到来自六大洲 141 个国家的 3101 份回复。88.3%的人表示他们的国家处于“全面封锁”状态,7.1%的人处于部分封锁状态。78.8%的人表示自冠状病毒爆发以来,出现 STEMI 的患者数量减少,65.2%的人表示 STEMI 患者减少超过 40%。大约 60%的受访者报告称 STEMI 患者就诊时间晚于往常,58.5%的人表示超过 40%的 STEMI 患者入院时间超过了直接经皮冠状动脉介入治疗(PCI)或溶栓治疗的最佳时间窗口。报告的 STEMI 就诊延迟率较高的独立预测因素是国家处于全面封锁状态、当地收治的 COVID-19 病例超过 100 例,以及当地心脏病学服务的全面重组。

结论

该调查表明,COVID-19 对 STEMI 就诊的影响可能很大,就诊人数减少,就诊延迟率更高。这对未来在发生这种大流行的进一步浪潮时的医疗保健和政策规划具有重要意义。

相似文献

1
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology.COVID-19 大流行期间 STEMI 患者入院情况:欧洲心脏病学会调查。
Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):210-216. doi: 10.1093/ehjqcco/qcaa046.
2
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.COVID-19 对 ST 段抬高型心肌梗死经皮冠状动脉介入治疗的影响。
Heart. 2020 Dec;106(23):1805-1811. doi: 10.1136/heartjnl-2020-317650. Epub 2020 Aug 31.
3
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.COVID-19 大流行与英格兰急性冠状动脉综合征的入院率及治疗管理。
Lancet. 2020 Aug 8;396(10248):381-389. doi: 10.1016/S0140-6736(20)31356-8. Epub 2020 Jul 14.
4
Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown?在新冠疫情封锁期间,ST段抬高型心肌梗死病例都去哪儿了?
Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):223-224. doi: 10.1093/ehjqcco/qcaa034.
5
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub.COVID-19 大流行期间的 ST 段抬高型心肌梗死:区域性公共服务医疗中心的观察结果。
Circ Cardiovasc Interv. 2020 Aug;13(8):e009413. doi: 10.1161/CIRCINTERVENTIONS.120.009413. Epub 2020 Aug 14.
6
Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China.中国 COVID-19 大流行期间 STEMI 患者的管理和结局。
J Am Coll Cardiol. 2020 Sep 15;76(11):1318-1324. doi: 10.1016/j.jacc.2020.06.039. Epub 2020 Aug 19.
7
Community and healthcare system-related factors feeding the phenomenon of evading medical attention for time-dependent emergencies during COVID-19 crisis.在新冠疫情危机期间,导致因时间紧迫的紧急情况而逃避就医现象的社区及医疗系统相关因素。
BMJ Case Rep. 2020 Aug 25;13(8):e237817. doi: 10.1136/bcr-2020-237817.
8
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.2019冠状病毒病大流行期间ST段抬高型心肌梗死的治疗
Cardiovasc Revasc Med. 2020 Aug;21(8):1024-1029. doi: 10.1016/j.carrev.2020.05.027. Epub 2020 May 21.
9
Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).COVID-19 大流行期间急性心肌梗死的管理:心血管血管造影和介入学会(SCAI)、美国心脏病学会(ACC)和美国急诊医师学会(ACEP)的共识声明。
Catheter Cardiovasc Interv. 2020 Aug;96(2):336-345. doi: 10.1002/ccd.28946. Epub 2020 May 13.
10
In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.新冠肺炎疫情前后急性心肌梗死患者的院内管理和结局。
J Cardiovasc Pharmacol. 2020 Nov;76(5):540-548. doi: 10.1097/FJC.0000000000000909.

引用本文的文献

1
Presentation of a residual post-myocardial infarction ventricular septal defect; a literature review based on a case report.心肌梗死后室间隔缺损残余的病例报告;基于病例报告的文献综述
J Cardiothorac Surg. 2025 May 9;20(1):230. doi: 10.1186/s13019-025-03440-8.
2
Mortality analysis of patients with acute coronary syndrome receiving comprehensive cardiac care (KOS-Zawal) during the COVID-19 pandemic period.COVID-19大流行期间接受全面心脏护理(KOS-Zawal)的急性冠状动脉综合征患者的死亡率分析
Arch Med Sci. 2024 Jun 6;21(1):60-66. doi: 10.5114/aoms/188089. eCollection 2025.
3
Impact of COVID-19 on door-to-wire time in ST-segment elevation myocardial infarction treatment: the role of digital communication.2019冠状病毒病对ST段抬高型心肌梗死治疗中门到导丝时间的影响:数字通信的作用
BMC Cardiovasc Disord. 2025 Mar 12;25(1):173. doi: 10.1186/s12872-025-04618-7.
4
The Impact of COVID-19 Infection on the Development of Stroke, Pulmonary Embolism, and Myocardial Infarction: A Retrospective Study.新型冠状病毒肺炎感染对中风、肺栓塞和心肌梗死发病的影响:一项回顾性研究
Cureus. 2025 Jan 19;17(1):e77665. doi: 10.7759/cureus.77665. eCollection 2025 Jan.
5
Impact of the COVID-19 Pandemic on Door-to-Device Time Segments and Clinical Outcomes for STEMI Patients in Northern Taiwan.2019冠状病毒病大流行对台湾北部ST段抬高型心肌梗死患者门到器械时间及临床结局的影响
Acta Cardiol Sin. 2025 Jan;41(1):121-129. doi: 10.6515/ACS.202501_41(1).20241021A.
6
The impact of SARS-CoV-2 on emergency health care demand: inverse relationship between COVID-like illnesses and ED accesses in Genoa, Italy.SARS-CoV-2 对急诊医疗需求的影响:意大利热那亚的 COVID 样疾病与急诊科就诊之间的反比关系。
J Prev Med Hyg. 2024 Aug 31;65(2):E154-E165. doi: 10.15167/2421-4248/jpmh2024.65.2.3279. eCollection 2024 Jun.
7
Outcomes of STEMI Patients in COVID-19 Pandemic: A Systematic Review and Meta-Analysis.COVID-19大流行期间ST段抬高型心肌梗死患者的结局:一项系统评价和荟萃分析。
Iran J Public Health. 2024 Sep;53(9):1964-1975. doi: 10.18502/ijph.v53i9.16451.
8
Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022.2020 年 3 月至 2022 年 3 月美国多波次 COVID-19 疫情期间心血管病超额死亡。
Nat Cardiovasc Res. 2023 Mar;2(3):322-333. doi: 10.1038/s44161-023-00220-2. Epub 2023 Feb 27.
9
The impact of coronavirus disease 2019 on acute coronary syndrome: Differences between epidemic waves.2019冠状病毒病对急性冠状动脉综合征的影响:疫情波次之间的差异
Am Heart J Plus. 2024 Jul 3;44:100422. doi: 10.1016/j.ahjo.2024.100422. eCollection 2024 Aug.
10
Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study.新冠疫情期间大型与小型心脏病科急性心力衰竭患者住院时间延长及院内死亡率更高:COV-HF-SIRIO 6多中心研究的亚分析
Rev Cardiovasc Med. 2022 Aug 24;23(9):292. doi: 10.31083/j.rcm2309292. eCollection 2022 Sep.

本文引用的文献

1
Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales.新冠大流行期间的超额死亡率:来自英格兰和威尔士的早期证据。
Soc Sci Med. 2020 Aug;258:113101. doi: 10.1016/j.socscimed.2020.113101. Epub 2020 Jun 1.
2
Impact of the COVID-19 Epidemic on Stroke Care and Potential Solutions.COVID-19 疫情对卒中护理的影响及潜在解决方案。
Stroke. 2020 Jul;51(7):1996-2001. doi: 10.1161/STROKEAHA.120.030225. Epub 2020 May 20.
3
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.新冠疫情与急性心肌梗死的发病率
N Engl J Med. 2020 Aug 13;383(7):691-693. doi: 10.1056/NEJMc2015630. Epub 2020 May 19.
4
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.意大利 COVID-19 时代心肌梗死住院人数减少。
Eur Heart J. 2020 Jun 7;41(22):2083-2088. doi: 10.1093/eurheartj/ehaa409.
5
Neurological Manifestations of COVID-19: A systematic review and current update.新型冠状病毒肺炎的神经系统表现:系统评价和最新进展。
Acta Neurol Scand. 2020 Jul;142(1):14-22. doi: 10.1111/ane.13266. Epub 2020 Jun 2.
6
Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.意大利北部新冠疫情期间急性冠状动脉综合征住院率降低
N Engl J Med. 2020 Jul 2;383(1):88-89. doi: 10.1056/NEJMc2009166. Epub 2020 Apr 28.
7
Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.自新冠疫情爆发以来奥地利急性冠脉综合征入院人数的下降:疫情应对措施导致心脏附带损害。
Eur Heart J. 2020 May 14;41(19):1852-1853. doi: 10.1093/eurheartj/ehaa314.
8
The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era.新冠疫情时代急诊科缺血性卒中消失的离奇病例
Eur Neurol. 2020;83(2):213-215. doi: 10.1159/000507666. Epub 2020 Apr 14.
9
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.新冠疫情期间美国ST段抬高型心肌梗死导管插入实验室激活率的降低
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872. doi: 10.1016/j.jacc.2020.04.011. Epub 2020 Apr 10.
10
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病(COVID-19)疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.